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Primary cardiac tumors are rare1 and about 75% are benign, of which 75% are atrialmyxomas.2 Angiosarcomas are the most common malignant primary cardiac tu-mors, with 90% arising in the left atrium and 10% in the right atrium.3 This is thefirst report of a primary cardiac tumor, an angiosarcoma, with a familial incidence.
Clinical Summaries
CASE 1. A previously healthy 24-year-old woman sought treatment with chest pain, exertional
dyspnea, and episodic dizziness. A transthoracic echocardiogram revealed an 8.9 ! 8.4-cm
right atrial mass, which was confirmed by computed tomography and magnetic resonance
imaging. This proved to be angiosarcoma (Figure 1). There were no distant metastases.
Surgery was aimed at debulking the tumor to alleviate obstructive symptoms. At operation,
the right atrial free wall was excised and reconstructed with a bovine pericardial patch (Baxter
Healthcare Corporation CardioVascular Group, Irvine, Calif), and the right ventricle was
debulked. Adjuvant chemotherapy was given. Four months after the operation the patient was
well, but at 6 months pulmonary metastases developed. The patient died 9 months after the
operation.
CASE 2. A previously healthy 31-year-old man, the father of the patient in case 1, sought
treatment in 1985 with shortness of breath, vague central discomfort, and anemia. Echocar-
diography showed a mass in the pericardial cavity and an echodense effusion. Computed
tomographic scan showed multiple secondary deposits in both lungs, right pleural effusion,
and a mass located anteriorly in the heart. Because of increasing dyspnea and possible
tamponade, pericardial drainage was attempted. This resulted in perforation of the right
ventricle, which was repaired with mattress sutures. The patient underwent adjuvant chemo-
therapy but died approximately 3 months after the operation with bilateral multiple pulmo-
nary metastases.
The cardiac tumors in cases 1 and 2 were histologically similar, composed of pleomorphic
spindle-shaped and epithelioid cells with high nuclear cytoplasmic ratios and eosinophilic
cytoplasm (Figure 2). In places these cells lined anastomosing vascular spaces. Both tumors
were immunopositive for endothelial antigens CD31 and CD34. These features indicate that
both tumors were angiosarcomas.
Cytogenetic studies were performed on tissue samples from case 1. Tumor tissue was
received within 24 hours of resection, and cell suspensions were obtained by mechanical and
trypsin-collagenase enzymatic treatment.4 Culture was established in flasks containing a
50:50 mixture of Ham F10 medium buffered with N-2-hydroxyethylpiperazine-N-2-ethane-
sulfonic acid and Roswell Park Memorial Institute medium buffered with bicarbonate, supple-
mented with 10% fetal calf serum, along with antibiotics and glutamine. Cells were grown in an
open system for 6 days and harvested according to standard techniques. Slides were analyzed by
Giemsa/Trypsin/Leishman banding. Although there was some variation from cell to cell, consis-
tent clonal chromosome changes are described in the following composite karyotype (Figure 3):
50-51, XX,"1[5],der(1;13)(ql0;ql0)[3],"2[5],"7[5],"8[5], add(8)(p2?)!2[6], " add(8)(p23)[2],
"18[3],#19[4],"22[4][cp6].
The abnormalities are mainly numeric, with gains of chromosomes 1, 2, 7, 8, and 22 and
monosomy 19. The most noteworthy abnormality was the presence in all cells of two copies
of an unbalanced rearrangement of 8p, producing loss of distal 8p.
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Figure 1. Right atrial cardiac angiosarcoma. Figure 2. Cardiac angiosarcoma from case 2 (father), showing
small blood vessels lined by neoplastic endothelial cells in
stroma of malignant spindle-shaped endothelial cells.
Figure 3. A, Representative karyotype of case 1 (daughter) showing all chromosome changes. There is an
unbalanced whole-arm der(1;13) translocation giving rise to relative 1p loss, and two copies of unbalanced
rearrangement of 8p, producing loss of distal 8p. Some cells also contained rearrangement of 8p23 in third
chromosome 8. Full composite karyotype formula is shown in the text. B, Partial karyotype of case 1 (daughter)
showing normal chromosome 8 and two copies of add(8p) abnormality. Arrows on normal 8 and on idiogram
indicate probable site of break.
Comment
Primary tumors have been recognized as rare cardiac diseases
since Columbus of Padua’s description in 1559. The first antemor-
tem diagnosis was recorded in 1934. The introduction of echocar-
diography in 1968 revolutionized the diagnosis of these tumors,
allowing their preoperative localization. Magnetic resonance im-
aging can define the extent of invasion and may allow histogenetic
classification.
Most malignant cardiac tumors are sarcomas.5 Angiosarcomas
are the most common sarcomas,3 accounting for 26% to 37%.
They commonly occur in the right atrium, as do other malignant
tumors. Right atrial tumors, as in our case 1, are more likely to be
malignant than are left atrial tumors.6 As many as half of all right
atrial tumors are malignant. Twice as many men as women are
affected, in the opposite ratio to atrial myxomas.
There is little cytogenetic documentation of angiosarcomas,7
and at present no specific abnormalities are recognized. Our case
1 demonstrated a hyperdiploid karyotype with trisomy of chromo-
somes 1, 2, 7, 8, 18, and 22 and monosomy of chromosome 19. Of
particular interest was the presence of two copies (occasionally
three) of an unbalanced rearrangement of 8p. This appears to have
resulted in the loss of 8p2 to 8pter, a region frequently deleted in
solid tumors. Such homozygous loss suggests the possible involve-
ment of a tumor suppressor gene in this region. A number of
candidate genes on 8p have been described in other tumor types.
These include DLC1, a suggested candidate tumor suppressor gene
at 8p22-8p21.3 implicated in liver, prostate, lung, colorectal, and
breast cancers8; N33, a gene within a homozygous 8p22 deletion
seen in prostate cancer9; and PDGRL at 8p22-8p21.3, which is
involved in hepatocellular cancer.10 We therefore recommend fur-
ther investigation of 8p in angiosarcomas, with particular regard to
any possible loss of heterozygosity, to establish whether this
region plays a role in the pathogenesis of this tumor type.
Cardiac angiosarcomas usually have symptoms caused by four
pathophysiologic mechanisms but may also be found incidentally.
Obstruction of intracardiac blood flow or valves and caval obstruc-
tion can also occur. Local invasion may lead to arrhythmias,
pericardial effusion or tamponade, and sudden death from arrhyth-
mias or embolization. Eighty percent of patients have systemic
metastasis at the time of diagnosis. The most common presentation
is congestive heart failure (75%), followed by embolism, tachyar-
rhythmia, and chest pain.2 Our patients had three of these features.
Cardiac tumors may cause systemic or constitutional symptoms,
such as malaise and fever.
Wide surgical excision remains the cornerstone of surgical
management of cardiac tumors. It may be difficult to obtain tumor-
free margins because of local spread or distant metastases. Com-
plete resection is possible in as many as a third of cases.6 A few
patients with cardiac sarcomas have received transplants, although
the role of cardiac transplantation remains unclear.11,12 If resection
is incomplete, the tumor may recur even after chemotherapy and
the patient may die of metastatic disease. The long-term results are
poor, with an overall survival of less than 1 year. With unresect-
able sarcomas, radiation and chemotherapy with adriamycin give a
limited response.
This report describes a cardiac hemangiosarcoma in a 24-year-
old woman whose father had died at the age of 31 years of a
histologically and immunochemically identical tumor. We believe
that this is the first reported description in the literature of familial
angiosarcoma of the heart.
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